• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 多学科高依赖单位:米兰模式。

COVID-19 multidisciplinary high dependency unit: the Milan model.

机构信息

IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, Respiratory Unit and Cystic Fibrosis Adult Center, Via Francesco Sforza 35, 20122, Milan, Italy.

University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy.

出版信息

Respir Res. 2020 Oct 9;21(1):260. doi: 10.1186/s12931-020-01516-8.

DOI:10.1186/s12931-020-01516-8
PMID:33036610
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7545383/
Abstract

COVID-19 is a complex and heterogeneous disease. The pathogenesis and the complications of the disease are not fully elucidated, and increasing evidence shows that SARS-CoV-2 causes a systemic inflammatory disease rather than a pulmonary disease. The management of hospitalized patients in COVID-19 dedicated units is advisable for segregation purpose as well as for infection control. In this article we present the standard operating procedures of our COVID-19 high dependency unit of the Policlinico Hospital, in Milan. Our high dependency unit is based on a multidisciplinary approach. We think that the multidisciplinary involvement of several figures can better identify treatable traits of COVID-19 disease, early identify patients who can quickly deteriorate, particularly patients with multiple comorbidities, and better manage complications related to off-label treatments. Although no generalizable to other hospitals and different healthcare settings, we think that our experience and our point of view can be helpful for countries and hospitals that are now starting to face the COVID-19 outbreak.

摘要

COVID-19 是一种复杂且异质性的疾病。其发病机制和并发症尚未完全阐明,越来越多的证据表明,SARS-CoV-2 引起的是全身性炎症性疾病,而不仅仅是肺部疾病。将住院患者安置在 COVID-19 专用病房,不仅有助于隔离和感染控制,也有利于管理。本文介绍了米兰 Policlinico 医院 COVID-19 高依赖病房的标准操作流程。我们的高依赖病房基于多学科方法。我们认为,多名医生共同参与,可以更好地识别出 COVID-19 疾病的可治疗特征,及早发现可能迅速恶化的患者,尤其是合并多种基础疾病的患者,并更好地管理与超说明书治疗相关的并发症。尽管我们的经验和观点无法推广至其他医院和不同的医疗环境,但我们认为,对于现在才开始应对 COVID-19 疫情的国家和医院来说,这些经验和观点可能会有所帮助。

相似文献

1
COVID-19 multidisciplinary high dependency unit: the Milan model.COVID-19 多学科高依赖单位:米兰模式。
Respir Res. 2020 Oct 9;21(1):260. doi: 10.1186/s12931-020-01516-8.
2
Timely adaptation of a Pediatric Unit to COVID-19 emergency in Northern Italy: the experience of Fondazione IRCCS Policlinico San Matteo in Pavia.意大利北部一家儿科病房对新冠疫情紧急情况的及时应对:帕维亚圣马泰奥综合医院基金会的经验。
Acta Biomed. 2020 Sep 15;91(11-S):e2020004. doi: 10.23750/abm.v91i11-S.10300.
3
Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.意大利伦巴第大区新冠疫情期间的重症监护利用情况:应急响应中的早期经验与预测
JAMA. 2020 Apr 28;323(16):1545-1546. doi: 10.1001/jama.2020.4031.
4
COVID-19 outbreak in Northern Italy: Viewpoint of the Milan area surgical community.意大利北部的新冠疫情:米兰地区外科界的观点
J Trauma Acute Care Surg. 2020 Jun;88(6):719-724. doi: 10.1097/TA.0000000000002695.
5
Promoting Better Clinical Trials and Drug Information as Public Health Interventions for the COVID-19 Emergency in Italy.促进更好的临床试验和药物信息作为意大利 COVID-19 紧急情况的公共卫生干预措施。
Ann Intern Med. 2020 Oct 20;173(8):654-655. doi: 10.7326/M20-3775. Epub 2020 Jun 16.
6
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
7
Setup of a Dedicated Coronavirus Intensive Care Unit: Logistical Aspects.设立专门的冠状病毒重症监护病房:后勤方面
Anesthesiology. 2020 Jul;133(1):244-246. doi: 10.1097/ALN.0000000000003325.
8
Providing optimal interventional oncology procedures at one of the COVID-19 referral center in Italy.在意大利的一家 COVID-19 转诊中心提供最佳的介入肿瘤学治疗。
Med Oncol. 2020 Aug 9;37(9):83. doi: 10.1007/s12032-020-01405-6.
9
Neonatal Transport and COVID-19 outbreak.新生儿转运与新冠疫情
Air Med J. 2020 May-Jun;39(3):154-155. doi: 10.1016/j.amj.2020.03.003. Epub 2020 Mar 31.
10
SARS-CoV-2 invades the West. How to face a COVID-19 epidemic in Lombardy, Northern Italy?严重急性呼吸综合征冠状病毒2侵入西方。如何应对意大利北部伦巴第大区的新型冠状病毒肺炎疫情?
Infez Med. 2020;28(2):133-134.

引用本文的文献

1
Intermediate care units: an effective alternative to reduce intensive care unit admissions-a prospective cohort study.中间护理单元:减少重症监护病房收治的有效替代方案——一项前瞻性队列研究
Intern Emerg Med. 2025 Aug 19. doi: 10.1007/s11739-025-04083-2.
2
Exploring Italian healthcare facilities response to COVID-19 pandemic: Lessons learned from the Italian Response to COVID-19 initiative.探索意大利医疗机构应对 COVID-19 大流行的措施:从意大利应对 COVID-19 倡议中吸取的经验教训。
Front Public Health. 2023 Jan 9;10:1016649. doi: 10.3389/fpubh.2022.1016649. eCollection 2022.
3
Characteristics and Outcomes of Critically Ill Pregnant/Postpartum Women with COVID-19 Pneumonia in Western Balkans, The Republic of Srpska Report.西巴尔干地区斯普斯卡共和国报告:COVID-19 肺炎危重症孕妇/产后女性的特征和结局。
Medicina (Kaunas). 2022 Nov 26;58(12):1730. doi: 10.3390/medicina58121730.
4
The COVID-19 pandemic response and its impact on post-corona health emergency and disaster risk management in Italy.意大利应对 COVID-19 大流行的措施及其对新冠疫情后卫生应急和灾害风险管理的影响。
Front Public Health. 2022 Oct 31;10:1034196. doi: 10.3389/fpubh.2022.1034196. eCollection 2022.
5
The Mortality Risk and Pulmonary Fibrosis Investigated by Time-Resolved Fluorescence Spectroscopy from Plasma in COVID-19 Patients.通过时间分辨荧光光谱法研究新冠病毒肺炎患者血浆中的死亡风险与肺纤维化
J Clin Med. 2022 Aug 30;11(17):5081. doi: 10.3390/jcm11175081.
6
Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study.意大利米兰内科病房第一波和第二波 COVID-19 之间的比较:一项回顾性观察研究。
Intern Emerg Med. 2022 Nov;17(8):2219-2228. doi: 10.1007/s11739-022-03052-3. Epub 2022 Aug 15.
7
Impact of establishing a respiratory high dependency unit for SCAP patients on the therapeutic effect, prognosis, and expenditure: a retrospective case-control study.建立呼吸重症监护病房对 SCAP 患者治疗效果、预后和支出的影响:一项回顾性病例对照研究。
Sci Rep. 2022 Jun 23;12(1):10703. doi: 10.1038/s41598-022-14705-w.
8
Incidence, clinical associations and outcomes of intrathoracic complications with and without ARDS in COVID-19 pneumonia.COVID-19 肺炎中合并和不合并 ARDS 的胸腔内并发症的发生率、临床相关性和结局。
Clin Imaging. 2022 May;85:106-114. doi: 10.1016/j.clinimag.2022.02.029. Epub 2022 Mar 4.
9
HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study.新冠患者中的高密度脂蛋白:来自一项意大利横断面研究的证据。
J Clin Med. 2021 Dec 18;10(24):5955. doi: 10.3390/jcm10245955.
10
Multidisciplinary Effort and Integrative Preparedness: A Lesson for the Foreseen Multivariate COVID-19 Pandemic Flare-Up.多学科协作与综合准备:应对可预见的多变量新冠疫情爆发的经验教训。
J Multidiscip Healthc. 2021 Oct 14;14:2905-2921. doi: 10.2147/JMDH.S332049. eCollection 2021.

本文引用的文献

1
Tocilizumab in patients with severe COVID-19: a retrospective cohort study.托珠单抗治疗重症新型冠状病毒肺炎患者:一项回顾性队列研究
Lancet Rheumatol. 2020 Aug;2(8):e474-e484. doi: 10.1016/S2665-9913(20)30173-9. Epub 2020 Jun 24.
2
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
3
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.羟氯喹、阿奇霉素和联合治疗 COVID-19 住院患者。
Int J Infect Dis. 2020 Aug;97:396-403. doi: 10.1016/j.ijid.2020.06.099. Epub 2020 Jul 2.
4
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.在患有新冠肺炎、急性呼吸窘迫综合征和炎症反应过度的患者中使用高剂量阿那白滞素进行白细胞介素-1阻断:一项回顾性队列研究。
Lancet Rheumatol. 2020 Jun;2(6):e325-e331. doi: 10.1016/S2665-9913(20)30127-2. Epub 2020 May 7.
5
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.COVID-19 患者接受抗栓治疗时的静脉血栓栓塞症的系统评估:发生率和 D-二聚体作为预测因素的作用。
J Thromb Thrombolysis. 2020 Jul;50(1):211-216. doi: 10.1007/s11239-020-02146-z.
6
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy.意大利米兰托珠单抗超适应证治疗严重急性呼吸综合征冠状病毒 2 型肺炎。
Eur J Intern Med. 2020 Jun;76:36-42. doi: 10.1016/j.ejim.2020.05.011. Epub 2020 May 21.
7
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
8
Complement activation in patients with COVID-19: A novel therapeutic target.新型冠状病毒肺炎患者的补体激活:一个新的治疗靶点。
J Allergy Clin Immunol. 2020 Jul;146(1):215-217. doi: 10.1016/j.jaci.2020.05.006. Epub 2020 May 14.
9
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.羟氯喹治疗需要吸氧的 COVID-19 肺炎患者的临床疗效:利用常规护理数据进行的观察性对比研究。
BMJ. 2020 May 14;369:m1844. doi: 10.1136/bmj.m1844.
10
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高:一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.